ISSN: 2167-7700
+44 1223 790975
Omer Sager , Selcuk Demiral, Ferrat Dincoglan, Murat Beyzadeoglu
Small Cell Lung Cancer (SCLC) is an aggressive subtype of lung cancer, however, response to chemotherapy and radiation therapy (RT) may be satisfactory in selected patients. Chemotherapy is a main therapeutic modality for management of SCLC which may result in significant tumor shrinkage. In this study, we evaluated tumor size
changes after upfront one cycle of chemotherapy for SCLC.
Published Date: 2020-11-23; Received Date: 2020-11-02